Close

Anthera Pharma (ANTH) Announces CHABLIS-SC1 Trial Missed Primary Endpoint in Active SLE

Go back to Anthera Pharma (ANTH) Announces CHABLIS-SC1 Trial Missed Primary Endpoint in Active SLE